The CDC has awarded Helix a contract to study how human genetics may influence COVID-19 vaccine efficacy, the population genomics and viral surveillance company said Jan. 4.
Read the full post on Becker's Hospital Review - Healthcare News
Why are some breakthrough COVID-19 cases severe? CDC seeks answers
